Repository of Research and Investigative Information

Repository of Research and Investigative Information

Ilam University of Medical Sciences

Celiac disease in Iranian irritable bowel syndrome patients; a systematic review and meta-analysis

Wed Feb 28 07:27:40 2024

(2019) Celiac disease in Iranian irritable bowel syndrome patients; a systematic review and meta-analysis. Gastroenterology and hepatology from bed to bench. pp. 85-97. ISSN 2008-2258 (Print) 2008-2258 (Linking)

Full text not available from this repository.

Official URL: https://www.ncbi.nlm.nih.gov/pubmed/31191832

Abstract

Aim: The present study was conducted to evaluate the prevalence, clinical symptoms and pathological findings of celiac disease (CD) in irritable bowel syndrome (IBS) patients in Iran. Background: Several studies show high prevalence of CD in IBS patients, but the results are contradictory. Methods: The present study was conducted based on MOOSE protocol and results were reported according to PRISMA guideline. The search was done using international online databases (Scopus, PubMed, Science Direct, Cochrane Library, Embase, and Web of Science), national databases and Google Scholar search engine. Results: The pooled prevalence of CD in 2,367 Iranian IBS patients was estimated to be 6.13 (95CI: 4.11-9.05). The prevalence of CD in men and women with IBS was 4.28 (95 CI: 2.45-7.37) and 7.19 (95 CI: 4.51-11.28), respectively. The serological prevalence of anti tTG-IgA (11 studies with 2901 IBS patients) and AGA-IgG (4 studies with 936 IBS patients) was estimated to be 5.35 (95CI: 3.60-7.89) and 6.35 (95CI: 2.05-18.03), respectively. The clinical symptoms of CD among IBS patients included predominant diarrhea (47.87 95%CI: 22.46-74.43), predominant constipation (17.34% 95%CI: 9.17-30.35), and alternative diarrhea and constipation (27.84% 95%CI: 11.57-53.23). According to pathological findings based on marsh classification, the prevalence of CD at stages 1, 2 and 3 were 30.89% (95%CI: 13.25-56.68), 36.56% (95%CI: 21.74-54.45) and 52.87% (95%CI: 14.48-88.13), respectively. Conclusion: In the present meta-analysis, we observed a high prevalence for CD among Iranian IBS patients, which is higher than global estimates. Examination of all IBS patients in terms of CD seems to be necessary, but cost-effectiveness should be considered.

Item Type: Article
Creators:
CreatorsEmail
Azami, M.UNSPECIFIED
Badfar, G.UNSPECIFIED
Abangah, G.UNSPECIFIED
Mahmoudi, L.UNSPECIFIED
Keywords: Celiac disease Iran Irritable bowel syndrome Meta-Analysis
Divisions:
Page Range: pp. 85-97
Journal or Publication Title: Gastroenterology and hepatology from bed to bench
Journal Index: Pubmed
Volume: 12
Number: 2
ISSN: 2008-2258 (Print) 2008-2258 (Linking)
Depositing User: مهندس مهدی شریفی
URI: http://eprints.medilam.ac.ir/id/eprint/2473

Actions (login required)

View Item View Item